Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Denosumab on Pain and Bone Marrow Lesions in Symptomatic Knee Osteoarthritis
2016-000754-35Phase 2Completed
- Sponsor
- The University of Manchester
- Start
- May 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Denosumab 60 mg SC with Placebo SC (2 arms). Primary endpoint: Change in total bone marrow lesion area. Started May 2018; status: completed.
02
Drugs
denosumab
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2016-000754-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000754-35.